Mohammad Khairi Mokthar is currently a Senior Lecturer at the Dance Department of the Faculty of Creative Arts at Universiti Malaya. He completed his doctoral studies at Universiti Malaya, specializing in ethnography with a focus on Terinai, a traditional Malay Classical Dance of Perlis. He holds a Master of Fine Arts in Dance Performance, with a major in contemporary dance, from Korea National University of Arts, (K'ARTS) Korea, where he was awarded a scholarship by the Korea Ministry of Culture, Sports, and Tourism. His dance journey began during his teenage years when he was exposed to Malay traditional dance. He pursued his tertiary dance education at the National Academy of Arts, Culture, and Heritage (ASWARA), Malaysia, where he received formal training in various dance forms, including Malay classical and folk dance, Chinese folk dance, ethnic dance, and Indian classical dance. He completed his Diploma in Dance in 2010 and his Bachelor of Dance (Performance) in 2013 at ASWARA. In 2013, he made his debut as an Indian classical dancer with a Bharatanatyam Arangetram. He has also worked professionally, including as a principal dancer at ASK Dance Company and in England with the Shobana Jeyasingh Dance for the Classic Cut Tour in 2012 and 2013. He has received numerous awards and recognitions for his contributions to dance, including Best Choreographer in Full-length Work at the 12th BOH Cameronian Arts Awards Malaysia in 2015, 2nd prize in the Seoul International Dance Competition in 2015 and 2016, and being named one of the Top 10 New Generation Malaysian Cultural Dancers in 2017. In addition to his performance work, Mohammad Khairi Mokthar has also served as a part-time lecturer and coach at various institutions, including Sultan Idris Education University (UPSI) and ASWARA. He received The Shining Star Awards in 2019, organized by the Uniques Arts Culture and Heritage Foundation in collaboration with the Ministry of Tourism, Arts, and Culture Malaysia. In 2019, he collaborated with choreographer Mavin Khoo and TFA Inner Space Dance Company for a performance titled "I am Ravana" at Sadler's Wells in London. He is recognized as an educator, choreographer, dancer, and scholar in the field of dance.

Dr. Chang Jindong is an Associate Professor at the School of Physical Education of Southwest University, Director of the Institute of Motor Quotient at Southwest University, and an Associate Researcher at the Faculty of Sport and Exercise Sciences of the Universiti Malaya. He served as a visiting scholar at the University of Illinois at Urbana-Champaign, and was recognized as the first sports science and technology expert in Chongqing. From 2015 to 2016, he was seconded to the Quality Monitoring Center for Basic Education of the Ministry of Education of China to contribute to the development of the National Physical Education and Health Monitoring and Evaluation Program for students in compulsory education. He currently serves as the deputy editor-in-chief of Chongqing Sports Science, as well as an editorial board member and academic editor of PLOS ONE. His research primarily focuses on movement measurement and evaluation (including children’s and adolescents’ motor quotient), motor skill learning and control, sports health and promotion, physical education curriculum and pedagogy, and the application of artificial intelligence and big data technology in physical education and public health.

Dr. Hassan Almoustafa is currently working as a Lecturer at Department of Pharmacology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia. Before joining UM faculty of Medicine as a PhD student he practiced Community Pharmacy in Syria while obtaining a masters degree in biomedical engineering from the University of Aleppo. He obtained his PhD from Faculty of Medicine, University of Malaya in 2021 where he had his Post Doctoral Research Fellowship. His area of expertise is drug delivery and his research interests are Nanomedicine in cancer treatment particulary polymeric nanoparticle formulations and the industrial scale up of Nanotechnology based medications.